Ardelyx | ARDX - Operating Expenses

Stock Price
5.86
Daily Change
0.08 1.38%
Monthly
-13.31%
Yearly
8.12%
Q1 Forecast
5.61

Ardelyx reported $105.66M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Abbott USD 9.21B 17M Dec/2025
Amgen USD 5.9B 773M Dec/2025
Ardelyx USD 105.66M 6.4M Sep/2025
aTyr Pharma USD 26.94M 6.63M Sep/2025
Corcept Therapeutics USD 197.64M 219K Dec/2025
Curis USD -13.99M 7.38M Jun/2025
Sanofi EUR 10.71B 1.32B Dec/2025
TG Therapeutics USD 142.08M 9.74M Dec/2025
United Therapeutics USD 804.8M 5.79B Dec/2025
Xoma USD 22.84M 1.67M Sep/2024